Visual acuity and contrast sensitivity are two important factors affecting vision-related quality of life in advanced age-related macular degeneration

被引:45
|
作者
Roh, Miin [1 ]
Selivanova, Alexandra [1 ]
Shin, Hyun Joon [2 ]
Miller, Joan W. [1 ]
Jackson, Mary Lou [3 ]
机构
[1] Harvard Med Sch, Dept Ophthalmol, Massachusetts Eye & Ear, Boston, MA USA
[2] Harvard Med Sch, Dept Med, VA Boston Hlth Care syst, Div Aging,Brigham & Womens Hosp, Boston, MA USA
[3] VGH Univ British Coumbia, Eye Care Ctr, Vancouver, BC, Canada
来源
PLOS ONE | 2018年 / 13卷 / 05期
关键词
FUNCTION QUESTIONNAIRE; ASSOCIATION; DISABILITY; VALIDITY; THERAPY;
D O I
10.1371/journal.pone.0196481
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Purpose Vision loss from age-related macular degeneration (AMD) has a profound effect on vision-related quality of life (VRQoL). The pupose of this study is to identify clinical factors associated with VRQoL using the Rasch- calibrated NEI VFQ-25 scales in bilateral advanced AMD patients. Methods We retrospectively reviewed 47 patients (mean age 83.2 years) with bilateral advanced AMD. Clinical assessment included age, gender, type of AMD, high contrast visual acuity (VA), history of medical conditions, contrast sensitivity (CS), central visual field loss, report of Charles Bonnet Syndrome, current treatment for AMD and Rasch-calibrated NEI VFQ-25 visual function and socioemotional function scales. The NEI VFQ visual function scale includes items of general vision, peripheral vision, distance vision and near vision-related activity while the socioemotional function scale includes items of vision related-social functioning, role difficulties, dependency, and mental health. Multiple regression analysis (structural regression model) was performed using fixed item parameters obtained from the one-parameter item response theory model. Results Multivariate analysis showed that high contrast VA and CS were two factors influencing VRQoL visual function scale (beta = -0.25, 95% CI-0.37 to -0.12, p<0.001 and beta = 0.35, 95% CI 0.25 to 0.46, p<0.001) and socioemontional functioning scale (beta = -0.2, 95% CI -0.37 to -0.03, p = 0.023, and beta = 0.3, 95% CI 0.18 to 0.43, p = 0.001). Central visual field loss was not assoicated with either VRQoL visual or socioemontional functioning scale (beta = -0.08, 95% CI-0.28 to 0.12,p = 0.44 and beta = -0.09, 95% CI -0.03 to 0.16, p = 0.50, respectively). Conclusion In patients with vision impairment secondary to bilateral advanced AMD, high contrast VA and CS are two important factors affecting VRQoL.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Binocular Visual Field and Vision-Related Quality of Life in Patients With Hemianopia
    Burgos-Blasco, Barbara
    Perez-Garcia, Pilar
    Fernandez-Vigo, Jose, I
    Benito-Pascual, Blanca
    Hernandez-Garcia, Elena
    Saenz-Frances, Federico
    Santos-Bueso, Enrique
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2022, 42 (01) : E217 - E224
  • [32] Association between visual acuity, lesion activity markers and retreatment decisions in neovascular age-related macular degeneration
    Chakravarthy, Usha
    Pillai, Natasha
    Syntosi, Annie
    Barclay, Lorna
    Best, Catherine
    Sagkriotis, Alexandros
    EYE, 2020, 34 (12) : 2249 - 2256
  • [33] Use of Imaging Modalities in Real Life: Impact on Visual Acuity Outcomes of Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration in Germany
    Wachtlin, Joachim
    Spital, Georg
    Schmitz-Valckenberg, Steffen
    Liakopoulos, Sandra
    Voegeler, Jessica
    Mueller, Bettina
    Ziemssen, Focke
    JOURNAL OF OPHTHALMOLOGY, 2020, 2020
  • [34] Principal Cause of Poor Visual Acuity after Neovascular Age-Related Macular Degeneration Age-Related Eye Disease Study 2 Report Number 23
    Okeagu, Chinwenwa U.
    Agron, Elvira
    Vitale, Susan
    Domalpally, Amitha
    Chew, Emily Y.
    Keenan, Tiarnan D. L.
    OPHTHALMOLOGY RETINA, 2021, 5 (01): : 23 - 31
  • [35] Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab?
    Ross, A. H.
    Donachie, P. H. J.
    Sallam, A.
    Stratton, I. M.
    Mohamed, Q.
    Scanlon, P. H.
    Kirkpatrick, J. N.
    Johnston, R. L.
    EYE, 2013, 27 (01) : 56 - 64
  • [36] Visual function quality of life measure changes upon conversion to neovascular age-related macular degeneration in second eyes
    Paulus, Yannis M.
    Jefferys, Joan L.
    Hawkins, Barbara S.
    Scott, Adrienne W.
    QUALITY OF LIFE RESEARCH, 2017, 26 (08) : 2139 - 2151
  • [37] Effects of adiponectin polymorphisms on the risk of advanced age-related macular degeneration
    Cao, Guiqun
    Chen, Yulong
    Zhang, Jinlong
    Liu, Yulan
    Zhang, Ming
    Zhang, Kang
    Su, Zhiguang
    BIOMARKERS, 2015, 20 (04) : 266 - 270
  • [38] The association between legal Japanese visual impairment grades and vision-related quality of life
    Kawashima, Motoko
    Hiratsuka, Yoshimune
    Nakano, Tadashi
    Tamura, Hiroshi
    Ono, Koichi
    Murakami, Akira
    Inoue, Sachiko
    Tsubota, Kazuo
    Yamada, Masakazu
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2016, 60 (03) : 219 - 225
  • [39] Financial burden and quality of life of informal caregivers of patients with wet age-related macular degeneration
    Weyer-Wendl, Hannah
    Walter, Peter
    HEALTH ECONOMICS REVIEW, 2016, 6
  • [40] Factors influencing vision-related quality of life according to glaucoma severity
    Chun, Yeoun Sook
    Sung, Kyung Rim
    Park, Chan Kee
    Kim, Hwang Ki
    Yoo, Chungkwon
    Kim, Yong Yeon
    Park, Ki Ho
    Kim, Chan Yun
    Choi, Kyu-Ryong
    Lee, Kyoo Won
    Han, Seungbong
    Kim, Chang Sik
    ACTA OPHTHALMOLOGICA, 2019, 97 (02) : E216 - E224